<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Holmes | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/cordramie2/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/cordramie2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Holmes.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9e3435f0cadb3108765e27c55fe3882d</guid>
				<title>Holmes posted an update: Altogether, our study illustrates that mitochondrial [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38255/</link>
				<pubDate>Tue, 04 Feb 2025 10:30:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Altogether, our study illustrates that mitochondrial dysfunction and redox perturbation is the major cause of the poor quality of oocytes exposed to EGBE.Administration of plerixafor with granulocyte-colony stimulating factor (G-CSF) mobilizes CD34+ cells much more effectively than G-CSF alone, but cost generally limits plerixafor use to patients&hellip;<span class="activity-read-more" id="activity-read-more-38255"><a href="http://www.nationalboardinstitute.com/activity/p/38255/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8dc01aaf216cdd3e67ab0981185c8ca2</guid>
				<title>Holmes posted an update: ess, it is imperative that research studies purposefully [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35672/</link>
				<pubDate>Sat, 01 Feb 2025 10:38:04 -0800</pubDate>

									<content:encoded><![CDATA[<p>ess, it is imperative that research studies purposefully recruit, retain, analyze, and report female veteran statistics along with their male counterparts. We can no longer afford to disregard the value of the female veterans&#8217; perspective.</p>
<p>The female veteran population is increasing and becoming more ethnically diverse. Female veterans are not&hellip;<span class="activity-read-more" id="activity-read-more-35672"><a href="http://www.nationalboardinstitute.com/activity/p/35672/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5d881d05c6c8100f96bd2c4fb45ecc7d</guid>
				<title>Holmes posted an update: Day 7 FA in edematous CST (0.35±0.08) was also decreased [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32353/</link>
				<pubDate>Tue, 28 Jan 2025 18:22:32 -0800</pubDate>

									<content:encoded><![CDATA[<p>Day 7 FA in edematous CST (0.35±0.08) was also decreased compared to contralateral CST (0.54±0.06; p&lt;0.0001). FA remained stable between 72h (0.37±0.03) and day 7 (0.35±0.07; p=0.350). FA at 72h (ρ=-0.22, p=0.420) and day 7 (ρ=-0.14, p=0.624) was unrelated to 90-day motor score.</p>
<p> FA is decreased in the CST where it passes through the edema&hellip;<span class="activity-read-more" id="activity-read-more-32353"><a href="http://www.nationalboardinstitute.com/activity/p/32353/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ba56e70762a03804eec9d205b70fe03d</guid>
				<title>Holmes became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32330/</link>
				<pubDate>Tue, 28 Jan 2025 18:19:09 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>